Growth Opportunities Target larger medical device players and hospitals expanding minimally invasive lung treatments, leveraging SurgRx’s focus on pulmonary medical devices and recent conference participation to align with enterprise buyers and strategic partnerships.

Strategic Partnerships Leverage potential collaborations with major competitors’ suppliers or distributors by positioning SurgRx as a nimble, US-based supplier of innovative lung disease solutions seeking co-development or distribution alliances.

Executive Transitions Capitalize on leadership changes and new CFO appointment to reach finance and procurement teams with value-driven ROI storytelling around cost of care, reimbursement readiness, and scalable manufacturing.

Market Visibility capitalize on ongoing investor and industry conference presence to generate inbound interest from hospital networks and health systems seeking innovative minimally invasive therapies for severe lung disease.

SMB to Midmarket Given a lean employee base, pursue mid-market health systems and regional centers with tailored pilots and turnkey deployment plans that fit smaller sales cycles while expanding geographic footprint and revenue potential.